
-
Almeida wins time-trial to take Tour of Switzerland
-
Bublik sees off Medvedev to claim second title on grass in Halle
-
Feyi-Waboso banned for England tour to Argentina
-
US strikes on Iran: what we know
-
Alcaraz crowned king of Queen's for second time
-
US says strikes 'devastated' Iran's nuclear program
-
Bublik sees off Medvedev to claim fifth AFP title in Halle
-
Freed Belarus opposition figure urges Trump to help release all prisoners
-
Wave of syringe attacks mar France's street music festival
-
US intervention 'devastated' Iran's nuclear programme says Pentagon
-
Marc Marquez completes perfect Mugello weekend with Italian MotoGP triumph
-
Vondrousova warms up for Wimbledon with Berlin title
-
India still on top in first Test despite Brook fifty for England
-
Ukraine army chief vows to expand strikes on Russia
-
United behind Iran war effort, Israelis express relief at US bombing
-
Former England fast bowler David Lawrence dead at 61
-
At least three impacts in Israel during Iran missile attacks, 23 hurt
-
Trump says US strikes 'obliterated' Iran nuclear sites
-
Japan's high-tech sunscreens tap into skincare craze
-
Tesla expected to launch long-discussed robotaxi service
-
South Korea counts on shipbuilding to ease US tariff woes
-
Bombing Iran, Trump gambles on force over diplomacy
-
Trump says US attack 'obliterated' Iran nuclear sites
-
Itoje to Valetini: five to watch when the Lions face Australia
-
Wallabies confident but wary of wounded British and irish Lions
-
Utopia and fragile democracy at Art Basel fair
-
Freed Israeli hostage recounts 484-day nightmare in Gaza
-
River Plate frustrated by Monterrey in 0-0 stalemate
-
Panama cuts internet, cell phones in restive province
-
Tens of thousands join pro-Palestinian marches across Europe
-
Coach Penney unsure of return to Super Rugby champions Crusaders
-
Trump says US 'obliterated' Iran nuclear sites, threatens more
-
Olympic chief Kirsty Coventry's steeliness honed by hard knocks
-
Outgoing IOC president Thomas Bach faced mammoth challenges
-
Maro Itoje comes of age with Lions captaincy
-
Trump says US bombs Iran nuclear sites, joining Israeli campaign
-
In New York, Vermeer show reveals art of the love letter
-
Ex-members of secret US abortion group fear return to dark era
-
Trump says US launched 'very successful' attack on Iran nuclear sites
-
Man City squad must be trimmed: Guardiola
-
Minjee Lee grabs four-shot lead at 'brutal' Women's PGA Championship
-
Olympic balloon rises again in Paris
-
Inter Milan, Dortmund claim first wins at Club World Cup
-
South American teams lay down the gauntlet to Europe at Club World Cup
-
Fleetwood grabs PGA Travelers lead as top-ranked stars fade
-
'Lucky' Lamothe hat-trick guides Bordeaux-Begles into Top 14 final
-
Lamothe hat-trick guides Bordeaux-Begles into Top 14 final
-
UK PM Starmer says Kneecap should not perform Glastonbury
-
Inter Milan strike late to beat Urawa Reds at Club World Cup
-
Dortmund stars hide from sun at Club World Cup 'sauna'

Brazil's banana spider aids erectile dysfunction treatment
Three decades ago, Brazilian researchers began studying a curious side effect from banana spider bites: the toxin left victims with priapism, a painful and persistent erection.
The scientists were inspired to develop a synthetic molecule using some properties of the spider's poison to create a gel to treat erectile dysfunction, which is now undergoing promising clinical trials.
Covered in thick brown hair, and with a maximum size of up to 15 centimeters (six inches), the arachnid is one of the most poisonous in the world.
It is found in several South American countries, and was nicknamed for its common presence in banana plantations, but it is also called the "wandering spider" or "armed spider."
In the southeastern Brazilian state of Minas Gerais, it is found in rural areas as well as urban centers.
At the Ezequiel Dias Foundation (FUNED), a medical research center in the state's capital Belo Horizonte, a biologist delicately grabs one of the spiders with a pair of tweezers and stimulates its fangs to get a few drops of venom.
FUNED then sends the venom to the Federal University of Minas Gerais (UFMG) which has been researching which component could be replicated to treat erectile dysfunction, which affects tens of millions of men around the world.
"The venom is only used to learn the properties of the molecule" which causes the priapism in bite victims, said Maria Elena de Lima, a UFMG researcher.
Brazilian biotech company Biozeus has bought the patent for the molecule.
The company wants to sell it in an ointment, which would be rubbed on the penis when required, resulting in an erection in a few minutes, said de Lima.
The molecule triggers the release of nitric oxide, which is essential for an erection as it increases blood circulation and allows blood vessels to widen.
De Lima said the research could be especially useful in the fight against cancer, as men suffering prostate cancer often refuse a procedure to remove the prostate because it can damage nerves and lead to erectile dysfunction.
After the first phase of clinical trials was approved by Brazil's Anvisa regulatory agency, the medication has now moved into the second of three phases prior to being approved for sale.
De Lima said the discovery of a potential erectile dysfunction treatment was a message "not to destroy animals, even poisonous ones, because there is a real library of molecules that are still unknown."
Z.Ramadan--SF-PST